Loading…

Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukaemia

The aim of this study was to evaluate levels of serum soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin) as parameters of disease activity and to monitor the response to treatment in children with acute lympho...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pediatrics 1997-07, Vol.156 (7), p.537-540
Main Authors: HATZISTILIANOU, M, ATHANASSIADOU, F, AGGURIDAKI, C, CATRIU, D
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c344t-59bf1589b3489722a1e782fff3f6f6b6839f84165507ed867422db671483bbfa3
cites
container_end_page 540
container_issue 7
container_start_page 537
container_title European journal of pediatrics
container_volume 156
creator HATZISTILIANOU, M
ATHANASSIADOU, F
AGGURIDAKI, C
CATRIU, D
description The aim of this study was to evaluate levels of serum soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin) as parameters of disease activity and to monitor the response to treatment in children with acute lymphoblastic leukaemia (ALL). The above soluble adhesion molecules were determined in the serum of 35 children with ALL and 30 healthy children (control group) of the same age range. The samples were obtained before treatment, 6 months after the beginning of the treatment (remission of the disease), 6 months after the end of the treatment and during relapse of the disease. The mean levels of sICAM-1, sVCAM-1 and sE-selectin at the onset of the disease were 646.6 +/- 80.9 ng/ml, 1786 +/- 151.8 ng/ml and 140.5 +/- 17.3 ng/ml, respectively. These values were significantly higher (P < 0.001) than those of the control group, which were, 245.8 +/- 25.7 ng/ml, 798.6 +/- 78.9 ng/ml and 44.7 +/- 18.2 ng/ml respectively. During remission, the mean levels did not differ significantly from those of the control group. After the end of the treatment the mean levels again did not show any significant differences compared to the control group. During relapse the soluble adhesion molecule mean levels (923.9 +/- 110.1 ng/ml, 2945.7 +/- 349.9 ng/ml and 258.2 +/- 5.1 ng/ml) were significantly higher (P < 0.001) than those of the control group and also than those obtained during remission and after the end of the treatment (P < 0.001). Pearson's correlation coefficient r was computed in order to detect possible linear correlations between: (1) sICAM-1 and sVCAM-1 (r = 0.632); (2) sICAM-1 and sE-selectin (r = 0.788) and (3) sVCAM-1 and sE-selectin (r = 0.752). All three cases correspond to P < 0.001, thus indicating strong linear correlations. The levels of soluble circulating adhesion molecule levels can be utilized for monitoring disease activity of ALL and its response to treatment, as well as for early detection of relapse. Strong linear correlations between the three soluble adhesion molecules tested suggest that each of them may be sufficient as an indicator.
doi_str_mv 10.1007/s004310050657
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79169602</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1323148901</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-59bf1589b3489722a1e782fff3f6f6b6839f84165507ed867422db671483bbfa3</originalsourceid><addsrcrecordid>eNpd0EtLxDAUBeAgyjiOLl0KRcRdNa-myVIGXzDgRlcuSpImNmPajkmrzL83YhnQVS6cj0vuAeAUwSsEYXkdIaQkTQVkRbkH5ogSnCNYsn0wh4TCnCEhDsFRjGuYvEB8BmYCJ0XYHLwuXdCjl4Pr3rLY-1F5k8m6MdH1Xdb23qTUZN58Gh8z12W6cb4Opsu-3NBkUo9DSrftpumVl3FwOtnxXZrWyWNwYKWP5mR6F-Dl7vZ5-ZCvnu4flzerXBNKh7wQyqKCC0UoFyXGEpmSY2stscwyxTgRllPEigKWpuaspBjXipWIcqKUlWQBLn_3bkL_MZo4VK2L2ngvO9OPsUo3M8EgTvD8H1z3Y-jS3yqMUSIckoTyX6RDH2MwttoE18qwrRCsfhqv_jSe_Nm0dFStqXd6qjjlF1Muo5beBtlpF3cMpzvS4eQbv1yHnA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221960803</pqid></control><display><type>article</type><title>Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukaemia</title><source>Springer Link</source><creator>HATZISTILIANOU, M ; ATHANASSIADOU, F ; AGGURIDAKI, C ; CATRIU, D</creator><creatorcontrib>HATZISTILIANOU, M ; ATHANASSIADOU, F ; AGGURIDAKI, C ; CATRIU, D</creatorcontrib><description>The aim of this study was to evaluate levels of serum soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin) as parameters of disease activity and to monitor the response to treatment in children with acute lymphoblastic leukaemia (ALL). The above soluble adhesion molecules were determined in the serum of 35 children with ALL and 30 healthy children (control group) of the same age range. The samples were obtained before treatment, 6 months after the beginning of the treatment (remission of the disease), 6 months after the end of the treatment and during relapse of the disease. The mean levels of sICAM-1, sVCAM-1 and sE-selectin at the onset of the disease were 646.6 +/- 80.9 ng/ml, 1786 +/- 151.8 ng/ml and 140.5 +/- 17.3 ng/ml, respectively. These values were significantly higher (P &lt; 0.001) than those of the control group, which were, 245.8 +/- 25.7 ng/ml, 798.6 +/- 78.9 ng/ml and 44.7 +/- 18.2 ng/ml respectively. During remission, the mean levels did not differ significantly from those of the control group. After the end of the treatment the mean levels again did not show any significant differences compared to the control group. During relapse the soluble adhesion molecule mean levels (923.9 +/- 110.1 ng/ml, 2945.7 +/- 349.9 ng/ml and 258.2 +/- 5.1 ng/ml) were significantly higher (P &lt; 0.001) than those of the control group and also than those obtained during remission and after the end of the treatment (P &lt; 0.001). Pearson's correlation coefficient r was computed in order to detect possible linear correlations between: (1) sICAM-1 and sVCAM-1 (r = 0.632); (2) sICAM-1 and sE-selectin (r = 0.788) and (3) sVCAM-1 and sE-selectin (r = 0.752). All three cases correspond to P &lt; 0.001, thus indicating strong linear correlations. The levels of soluble circulating adhesion molecule levels can be utilized for monitoring disease activity of ALL and its response to treatment, as well as for early detection of relapse. Strong linear correlations between the three soluble adhesion molecules tested suggest that each of them may be sufficient as an indicator.</description><identifier>ISSN: 0340-6199</identifier><identifier>EISSN: 1432-1076</identifier><identifier>DOI: 10.1007/s004310050657</identifier><identifier>PMID: 9243236</identifier><identifier>CODEN: EJPEDT</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adolescent ; Antigens ; Biological and medical sciences ; Biomarkers, Tumor ; Case-Control Studies ; Cell adhesion &amp; migration ; Child ; Child, Preschool ; E-Selectin - blood ; Endothelium ; Hematologic and hematopoietic diseases ; Humans ; Infant ; Intercellular Adhesion Molecule-1 - blood ; Leukemia ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Leukocytes ; Medical prognosis ; Medical sciences ; Melanoma ; Metastasis ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy ; Prognosis ; Remission (Medicine) ; Severity of Illness Index ; Vascular Cell Adhesion Molecule-1 - blood</subject><ispartof>European journal of pediatrics, 1997-07, Vol.156 (7), p.537-540</ispartof><rights>1997 INIST-CNRS</rights><rights>Springer-Verlag Berlin Heidelberg 1997</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-59bf1589b3489722a1e782fff3f6f6b6839f84165507ed867422db671483bbfa3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2714348$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9243236$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HATZISTILIANOU, M</creatorcontrib><creatorcontrib>ATHANASSIADOU, F</creatorcontrib><creatorcontrib>AGGURIDAKI, C</creatorcontrib><creatorcontrib>CATRIU, D</creatorcontrib><title>Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukaemia</title><title>European journal of pediatrics</title><addtitle>Eur J Pediatr</addtitle><description>The aim of this study was to evaluate levels of serum soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin) as parameters of disease activity and to monitor the response to treatment in children with acute lymphoblastic leukaemia (ALL). The above soluble adhesion molecules were determined in the serum of 35 children with ALL and 30 healthy children (control group) of the same age range. The samples were obtained before treatment, 6 months after the beginning of the treatment (remission of the disease), 6 months after the end of the treatment and during relapse of the disease. The mean levels of sICAM-1, sVCAM-1 and sE-selectin at the onset of the disease were 646.6 +/- 80.9 ng/ml, 1786 +/- 151.8 ng/ml and 140.5 +/- 17.3 ng/ml, respectively. These values were significantly higher (P &lt; 0.001) than those of the control group, which were, 245.8 +/- 25.7 ng/ml, 798.6 +/- 78.9 ng/ml and 44.7 +/- 18.2 ng/ml respectively. During remission, the mean levels did not differ significantly from those of the control group. After the end of the treatment the mean levels again did not show any significant differences compared to the control group. During relapse the soluble adhesion molecule mean levels (923.9 +/- 110.1 ng/ml, 2945.7 +/- 349.9 ng/ml and 258.2 +/- 5.1 ng/ml) were significantly higher (P &lt; 0.001) than those of the control group and also than those obtained during remission and after the end of the treatment (P &lt; 0.001). Pearson's correlation coefficient r was computed in order to detect possible linear correlations between: (1) sICAM-1 and sVCAM-1 (r = 0.632); (2) sICAM-1 and sE-selectin (r = 0.788) and (3) sVCAM-1 and sE-selectin (r = 0.752). All three cases correspond to P &lt; 0.001, thus indicating strong linear correlations. The levels of soluble circulating adhesion molecule levels can be utilized for monitoring disease activity of ALL and its response to treatment, as well as for early detection of relapse. Strong linear correlations between the three soluble adhesion molecules tested suggest that each of them may be sufficient as an indicator.</description><subject>Adolescent</subject><subject>Antigens</subject><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor</subject><subject>Case-Control Studies</subject><subject>Cell adhesion &amp; migration</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>E-Selectin - blood</subject><subject>Endothelium</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Infant</subject><subject>Intercellular Adhesion Molecule-1 - blood</subject><subject>Leukemia</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Leukocytes</subject><subject>Medical prognosis</subject><subject>Medical sciences</subject><subject>Melanoma</subject><subject>Metastasis</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</subject><subject>Prognosis</subject><subject>Remission (Medicine)</subject><subject>Severity of Illness Index</subject><subject>Vascular Cell Adhesion Molecule-1 - blood</subject><issn>0340-6199</issn><issn>1432-1076</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNpd0EtLxDAUBeAgyjiOLl0KRcRdNa-myVIGXzDgRlcuSpImNmPajkmrzL83YhnQVS6cj0vuAeAUwSsEYXkdIaQkTQVkRbkH5ogSnCNYsn0wh4TCnCEhDsFRjGuYvEB8BmYCJ0XYHLwuXdCjl4Pr3rLY-1F5k8m6MdH1Xdb23qTUZN58Gh8z12W6cb4Opsu-3NBkUo9DSrftpumVl3FwOtnxXZrWyWNwYKWP5mR6F-Dl7vZ5-ZCvnu4flzerXBNKh7wQyqKCC0UoFyXGEpmSY2stscwyxTgRllPEigKWpuaspBjXipWIcqKUlWQBLn_3bkL_MZo4VK2L2ngvO9OPsUo3M8EgTvD8H1z3Y-jS3yqMUSIckoTyX6RDH2MwttoE18qwrRCsfhqv_jSe_Nm0dFStqXd6qjjlF1Muo5beBtlpF3cMpzvS4eQbv1yHnA</recordid><startdate>19970701</startdate><enddate>19970701</enddate><creator>HATZISTILIANOU, M</creator><creator>ATHANASSIADOU, F</creator><creator>AGGURIDAKI, C</creator><creator>CATRIU, D</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>19970701</creationdate><title>Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukaemia</title><author>HATZISTILIANOU, M ; ATHANASSIADOU, F ; AGGURIDAKI, C ; CATRIU, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-59bf1589b3489722a1e782fff3f6f6b6839f84165507ed867422db671483bbfa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adolescent</topic><topic>Antigens</topic><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor</topic><topic>Case-Control Studies</topic><topic>Cell adhesion &amp; migration</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>E-Selectin - blood</topic><topic>Endothelium</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Infant</topic><topic>Intercellular Adhesion Molecule-1 - blood</topic><topic>Leukemia</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Leukocytes</topic><topic>Medical prognosis</topic><topic>Medical sciences</topic><topic>Melanoma</topic><topic>Metastasis</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</topic><topic>Prognosis</topic><topic>Remission (Medicine)</topic><topic>Severity of Illness Index</topic><topic>Vascular Cell Adhesion Molecule-1 - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HATZISTILIANOU, M</creatorcontrib><creatorcontrib>ATHANASSIADOU, F</creatorcontrib><creatorcontrib>AGGURIDAKI, C</creatorcontrib><creatorcontrib>CATRIU, D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Family Health</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HATZISTILIANOU, M</au><au>ATHANASSIADOU, F</au><au>AGGURIDAKI, C</au><au>CATRIU, D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukaemia</atitle><jtitle>European journal of pediatrics</jtitle><addtitle>Eur J Pediatr</addtitle><date>1997-07-01</date><risdate>1997</risdate><volume>156</volume><issue>7</issue><spage>537</spage><epage>540</epage><pages>537-540</pages><issn>0340-6199</issn><eissn>1432-1076</eissn><coden>EJPEDT</coden><abstract>The aim of this study was to evaluate levels of serum soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin) as parameters of disease activity and to monitor the response to treatment in children with acute lymphoblastic leukaemia (ALL). The above soluble adhesion molecules were determined in the serum of 35 children with ALL and 30 healthy children (control group) of the same age range. The samples were obtained before treatment, 6 months after the beginning of the treatment (remission of the disease), 6 months after the end of the treatment and during relapse of the disease. The mean levels of sICAM-1, sVCAM-1 and sE-selectin at the onset of the disease were 646.6 +/- 80.9 ng/ml, 1786 +/- 151.8 ng/ml and 140.5 +/- 17.3 ng/ml, respectively. These values were significantly higher (P &lt; 0.001) than those of the control group, which were, 245.8 +/- 25.7 ng/ml, 798.6 +/- 78.9 ng/ml and 44.7 +/- 18.2 ng/ml respectively. During remission, the mean levels did not differ significantly from those of the control group. After the end of the treatment the mean levels again did not show any significant differences compared to the control group. During relapse the soluble adhesion molecule mean levels (923.9 +/- 110.1 ng/ml, 2945.7 +/- 349.9 ng/ml and 258.2 +/- 5.1 ng/ml) were significantly higher (P &lt; 0.001) than those of the control group and also than those obtained during remission and after the end of the treatment (P &lt; 0.001). Pearson's correlation coefficient r was computed in order to detect possible linear correlations between: (1) sICAM-1 and sVCAM-1 (r = 0.632); (2) sICAM-1 and sE-selectin (r = 0.788) and (3) sVCAM-1 and sE-selectin (r = 0.752). All three cases correspond to P &lt; 0.001, thus indicating strong linear correlations. The levels of soluble circulating adhesion molecule levels can be utilized for monitoring disease activity of ALL and its response to treatment, as well as for early detection of relapse. Strong linear correlations between the three soluble adhesion molecules tested suggest that each of them may be sufficient as an indicator.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>9243236</pmid><doi>10.1007/s004310050657</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0340-6199
ispartof European journal of pediatrics, 1997-07, Vol.156 (7), p.537-540
issn 0340-6199
1432-1076
language eng
recordid cdi_proquest_miscellaneous_79169602
source Springer Link
subjects Adolescent
Antigens
Biological and medical sciences
Biomarkers, Tumor
Case-Control Studies
Cell adhesion & migration
Child
Child, Preschool
E-Selectin - blood
Endothelium
Hematologic and hematopoietic diseases
Humans
Infant
Intercellular Adhesion Molecule-1 - blood
Leukemia
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Leukocytes
Medical prognosis
Medical sciences
Melanoma
Metastasis
Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Prognosis
Remission (Medicine)
Severity of Illness Index
Vascular Cell Adhesion Molecule-1 - blood
title Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukaemia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A32%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Circulating%20soluble%20adhesion%20molecule%20levels%20in%20children%20with%20acute%20lymphoblastic%20leukaemia&rft.jtitle=European%20journal%20of%20pediatrics&rft.au=HATZISTILIANOU,%20M&rft.date=1997-07-01&rft.volume=156&rft.issue=7&rft.spage=537&rft.epage=540&rft.pages=537-540&rft.issn=0340-6199&rft.eissn=1432-1076&rft.coden=EJPEDT&rft_id=info:doi/10.1007/s004310050657&rft_dat=%3Cproquest_cross%3E1323148901%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c344t-59bf1589b3489722a1e782fff3f6f6b6839f84165507ed867422db671483bbfa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=221960803&rft_id=info:pmid/9243236&rfr_iscdi=true